Comphya, a pioneering Swiss medical device company and proud spin-off from the renowned Swiss Federal Institute of Technology (EPFL), is thrilled to announce its recent funding milestone of CHF 8,000,000. This significant infusion of capital is set to propel the development and commercialization of their groundbreaking neuroprosthetic technology, specifically designed to address the critical clinical challenges associated with erectile dysfunction (ED) in spinal cord injury and post-prostatectomy patients. These patients, often non-responsive to conventional oral medications, stand to benefit immensely from Comphya’s innovative approach, which promises a much-needed solution where traditional treatments have fallen short. With a steadfast mission to enhance life quality for a vast segment of the male population, Comphya is dedicated to fulfilling unmet patient needs through safe, effective, and technologically advanced medical devices. The funding will empower the company to further refine their neuroprosthetic device, ensuring that it not only adheres to the highest standards of safety and efficacy but also undergoes rigorous clinical testing to validate its benefits for patients in need. In addition to research and development, a portion of the funds will be strategically allocated to expanding the team of experts and enhancing manufacturing capabilities to meet future demand. This expanded support network is expected to accelerate regulatory approval processes and facilitate the seamless integration of the new device into various healthcare settings worldwide. Ultimately, this investment marks a transformative moment for Comphya, reinforcing its commitment to revolutionizing ED treatment and improving patient care through innovative medical technology.
Comphya Secures $8M to Pioneer Neuroprosthetic Solutions for ED Treatment
Recently funded · €8.0MMedical Device
Get the full Comphya company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
